Home › HIV › NCT06730555

Advancing Access to HIV/HCV Testing for People Who Inject Drugs (PWID)

Project ACCESS: Advancing Access to HIV/HCV Testing Through Transformation in Syringe Services Programs: A Cluster Randomized Trial

Who can join

Ages 18 and older · All sexes · Healthy volunteers welcome

Inclusion Criteria:

* SSPs must:

  1. be operating in an Ending the HIV Epidemic (EHE) or Centers for Disease Control and Prevention (CDC) determined vulnerable jurisdictions;
  2. serve at least 300 unique participants per year;
  3. not currently offer opt-out HIV/HCV testing;
  4. be capable and willing to prospectively collect aggregated, site-level data on the number of participants who are: i) offered HIV/HCV screening, ii) completed these tests, and iii) linked to care, as well as provide participant demographics;
  5. have key staff that consent to participate in study surveys, qualitative interviews and practice facilitation throughout the study.

Exclusion Criteria:

* SSPs must not:

  1. currently receive or have received Frontline Communities in the United States (FOCUS) funding;
  2. have already implemented opt-out HIV/HCV testing.
  3. currently participating in SAIA-SSP-HIV (NCT06025435)

About the study

The purpose of this study is to test the effectiveness of the ACCESS strategy: an organizational-level intervention that uses funding and practice facilitation to improve the organizational capacity of syringe services programs (SSPs) to implement routine, opt-out HIV and Hepatitis C (HCV) testing and linkage to care for people who inject drugs (PWID).

What is being tested

• ACCESS Intervention (behavioral)
• Control Group (behavioral)

Sponsor: University of Miami · Participants: 40 · Started: Jun 27, 2025

Contact the study team

• Hansel Tookes, MD · Phone: 3056897030

Official record on ClinicalTrials.gov — NCT06730555

Locations in the U.S.

Conditions

• HIV

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.